ArticleBioengineered2022

Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model.

Xin Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.